Summary
A Phase IIb, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the safety, tolerability and efficacy of Study Drug in adults with chronic hepatitis C virus infection.
Register to download
PRA Exceeds Tough Enrollment Goals
You may also be interested in:
page
Therapeutic Expertise
Learn More
page
Infectious Diseases
We’ve supported more than 150 infectious disease studies, leading to the approval of 13 important marketed products.
Learn More
Case Study
Persistence Leads To High Enrollment
A Phase IV, randomized, single-blind, placebo-controlled, multi-center study to evaluate the immunogenicity of pneumococcal and influenza vaccines in…
View Resource
View all related content and resources for Infectious Diseases
Explore Insights